Literature DB >> 25205634

Impaired degranulation and proliferative capacity of Mycobacterium tuberculosis-specific CD8+ T cells in HIV-infected individuals with latent tuberculosis.

Ameeta S Kalokhe1, Toidi Adekambi2, Chris C Ibegbu3, Susan M Ray4, Cheryl L Day5, Jyothi Rengarajan6.   

Abstract

Human immunodeficiency virus (HIV)-infected individuals with latent Mycobacterium tuberculosis infection have substantially higher rates of progression to active tuberculosis than HIV-uninfected individuals with latent tuberculosis. To explore HIV-induced deficits in M. tuberculosis-specific CD8+ T-cell functions, we compared interferon γ production, degranulation, and proliferation of CD8+ T cells in response to M. tuberculosis peptides (ESAT-6/CFP-10) between HIV-infected (median CD4+ T-cell count, 522 cells/µL; interquartile range, 318-585 cells/µL) and HIV-uninfected individuals with latent tuberculosis from South Africa. We found that M. tuberculosis-specific degranulation and proliferative capacities were impaired in the HIV-infected group. Thus, our results suggest that HIV coinfection compromises CD8+ T-cell functions in latent tuberculosis.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD8+ T cells; HIV; degranulation; latent tuberculosis; proliferation

Mesh:

Year:  2014        PMID: 25205634      PMCID: PMC4351361          DOI: 10.1093/infdis/jiu505

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

Authors:  Michael R Betts; Jason M Brenchley; David A Price; Stephen C De Rosa; Daniel C Douek; Mario Roederer; Richard A Koup
Journal:  J Immunol Methods       Date:  2003-10-01       Impact factor: 2.303

2.  CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment.

Authors:  Charles B Holmes; Robin Wood; Motasim Badri; Sophia Zilber; Bingxia Wang; Gary Maartens; Hui Zheng; Zhigang Lu; Kenneth A Freedberg; Elena Losina
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-01       Impact factor: 3.731

3.  Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.

Authors:  Adam R Hersperger; Jeffrey N Martin; Lucy Y Shin; Prameet M Sheth; Colin M Kovacs; Gabriela L Cosma; George Makedonas; Florencia Pereyra; Bruce D Walker; Rupert Kaul; Steven G Deeks; Michael R Betts
Journal:  Blood       Date:  2011-02-02       Impact factor: 22.113

4.  Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-06-09

5.  Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.

Authors:  Joshua S Woodworth; Ying Wu; Samuel M Behar
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

6.  Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans.

Authors:  Heiko Bruns; Christoph Meinken; Philipp Schauenberg; Georg Härter; Peter Kern; Robert L Modlin; Christian Antoni; Steffen Stenger
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

7.  Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells.

Authors:  L A van Pinxteren; J P Cassidy; B H Smedegaard; E M Agger; P Andersen
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

8.  Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons.

Authors:  Cheryl L Day; Nompumelelo Mkhwanazi; Sharon Reddy; Zenele Mncube; Mary van der Stok; Paul Klenerman; Bruce D Walker
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

9.  Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection.

Authors:  Christof Geldmacher; Alexandra Schuetz; Njabulo Ngwenyama; Joseph P Casazza; Erica Sanga; Elmar Saathoff; Catharina Boehme; Steffen Geis; Leonard Maboko; Mahavir Singh; Fred Minja; Andreas Meyerhans; Richard A Koup; Michael Hoelscher
Journal:  J Infect Dis       Date:  2008-12-01       Impact factor: 5.226

10.  Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection.

Authors:  Christof Geldmacher; Njabulo Ngwenyama; Alexandra Schuetz; Constantinos Petrovas; Klaus Reither; Edwin J Heeregrave; Joseph P Casazza; David R Ambrozak; Mark Louder; William Ampofo; Georgios Pollakis; Brenna Hill; Erica Sanga; Elmar Saathoff; Leonard Maboko; Mario Roederer; William A Paxton; Michael Hoelscher; Richard A Koup
Journal:  J Exp Med       Date:  2010-11-29       Impact factor: 14.307

View more
  11 in total

1.  Impaired Cytokine but Enhanced Cytotoxic Marker Expression in Mycobacterium tuberculosis-Induced CD8+ T Cells in Individuals With Type 2 Diabetes and Latent Mycobacterium tuberculosis Infection.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Parakkal Jovvian George; Chandrakumar Dolla; Paul Kumaran; Subash Babu
Journal:  J Infect Dis       Date:  2015-10-20       Impact factor: 5.226

2.  Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Authors:  Toidi Adekambi; Chris C Ibegbu; Stephanie Cagle; Ameeta S Kalokhe; Yun F Wang; Yijuan Hu; Cheryl L Day; Susan M Ray; Jyothi Rengarajan
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

Review 3.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

4.  CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection.

Authors:  Taylor W Foreman; Smriti Mehra; Denae N LoBato; Adel Malek; Xavier Alvarez; Nadia A Golden; Allison N Bucşan; Peter J Didier; Lara A Doyle-Meyers; Kasi E Russell-Lodrigue; Chad J Roy; James Blanchard; Marcelo J Kuroda; Andrew A Lackner; John Chan; Shabaana A Khader; William R Jacobs; Deepak Kaushal
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

5.  Functional status of immune cells in patients with long-lasting type 2 diabetes mellitus.

Authors:  H W Nam; Y J Cho; J A Lim; S J Kim; H Kim; S Y Sim; D G Lim
Journal:  Clin Exp Immunol       Date:  2018-09-12       Impact factor: 4.330

6.  HLA-DRB1 genes and the expression dynamics of HLA CIITA determine the susceptibility to T2DM.

Authors:  Rathika Chinniah; Vandit Sevak; Sasiharan Pandi; Padma Malini Ravi; Murali Vijayan; Arun Kannan; Balakrishnan Karuppiah
Journal:  Immunogenetics       Date:  2021-03-22       Impact factor: 2.846

7.  An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression.

Authors:  Federico Perdomo-Celis; Paula A Velilla; Natalia A Taborda; María Teresa Rugeles
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

Review 8.  Abnormal Tryptophan Metabolism in HIV and Mycobacterium tuberculosis Infection.

Authors:  Xiaolei Wang; Smriti Mehra; Deepak Kaushal; Ronald S Veazey; Huanbin Xu
Journal:  Front Microbiol       Date:  2021-06-28       Impact factor: 5.640

9.  Nonpathogenic SIV and Pathogenic HIV Infections Associate with Disparate Innate Cytokine Signatures in Response to Mycobacterium bovis BCG.

Authors:  Melanie A Gasper; Shameek P Biswas; Bridget S Fisher; Stephanie C Ehnert; David R Sherman; Donald L Sodora
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

10.  Relationship Between HIV Coinfection, Interleukin 10 Production, and Mycobacterium tuberculosis in Human Lymph Node Granulomas.

Authors:  Collin R Diedrich; Jennifer O'Hern; Maximiliano G Gutierrez; Nafiesa Allie; Patricia Papier; Graeme Meintjes; Anna K Coussens; Helen Wainwright; Robert J Wilkinson
Journal:  J Infect Dis       Date:  2016-07-26       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.